Qualifying Condition Focus

Tourette’s Syndrome is pending approval to become a qualifying condition for the New Jersey Medical Marijuana Program. Tourette’s Syndrome is a nervous system disorder that causes sudden movements or sounds, called tics. The two types of tics are motor tics and vocal tics. Motor tics include arm or head jerking, blinking, making a face, mouth twitching or shoulder shrugging. Vocal tics include shouting, grunting, barking, yelping, clearing throats, repeating someone’s words and others.

 

Anecdotal evidence shows cannabis
to be helpful in treating symptoms of Tourette’s Syndrome.

More than 100,000 Americas have mild to severe Tourette’s Syndrome. The cause of Tourette’s syndrome is still widely unknown, but it’s thought that genes play a role in the disease. This syndrome has been linked to different parts of the brain, one of which is known as the basal ganglia, which helps control body movements. Treatment for Tourette’s Syndrome include pharmaceuticals that work with dopamine levels in the brain, blood pressure medicine and antidepressants.

Anecdotal evidence shows cannabis to be helpful in treating symptoms of Tourette’s Syndrome.
Muller-Vahl et. al found that cannabis sativa and THC had beneficial influences on the symptoms of Tourette’s Syndrome including a significant reduction of motor and vocal tics and obsessive-compulsive disorder using the self-rating scale.